Darbitop 25mcg Injection
Manufacturer
Alniche Life Sciences Pvt Ltd
Salt Composition
Darbepoetin alfa (25mcg)
Key Information
Short Description
Darbitop 25mcg Injection is used to treat anemia caused by chronic kidney disease or chemotherapy by stimulating the bone marrow to produce more red blood cells.
Dosage Form
Injection
Introduction
Darbitop 25mcg Injection is a medicine that needs to be used with utmost care because it can lead to serious side effects. It is important that you seek treatment from a doctor who is experienced in providing this medical therapy. You should follow all the directions of the doctor strictly. It is given under the supervision of a healthcare professional. Common side effects include abdominal pain, high blood pressure, rash, injection site pain, breathlessness, cough, and peripheral edema. Inform your doctor if there are symptoms of very high blood pressure such as severe headache, problems with your eyesight, nausea, vomiting, or fits (seizures). Your doctor may get your blood tests done regularly to monitor the levels of salts (electrolytes such as potassium), hemoglobin, and blood cells in your blood. You should stop taking it and consult with a doctor if you develop shortness of breath or skin rash. Before taking Darbitop 25mcg Injection, tell your doctor if you have heart disease, high blood pressure, or have had a seizure or stroke. If you are pregnant or breastfeeding, or plan to become pregnant or breastfeed, consult your doctor to make sure it is safe for you.
Directions for Use
Your doctor or nurse will give you this medicine. Kindly do not self-administer.
How it works
Darbitop 25mcg Injection is an erythropoiesis-stimulating agent (ESA). It works by stimulating the bone marrow (soft tissue inside the bones which produces red blood cells) to produce more red blood cells.
Quick Tips
Darbitop 25mcg Injection helps in the treatment of anemia that may have occurred due to chronic kidney disease or cancer chemotherapy. It is given as a single injection under your skin It can be given intravenously. Your doctor may get your blood tests done regularly to monitor the levels of hemoglobin, blood cells, in your blood. Stop taking Darbitop 25mcg Injection and inform your doctor if you develop shortness of breath or skin rash.
Frequently asked questions
What is the typical timeframe for noticing an increase in red blood cell count (hemoglobin levels) after starting Darbitop 25mcg Injection?
You can expect to see an increase in red blood cell count within 2-6 weeks of initiating treatment with Darbitop 25mcg Injection.
Is Darbitop 25mcg Injection a safe medication to use?
Darbitop 25mcg Injection is a medication that requires careful handling due to its potential for causing serious side effects, including death. It's essential to consult with an experienced doctor who has provided Darbitop 25mcg Injection therapy before using this medication.
What are the alternative reasons for not responding to Darbitop 25mcg Injection?
You may not respond to Darbitop 25mcg Injection if you have deficiencies in iron, folic acid, or vitamin B12. Other possible reasons include bleeding, infections, inflammation, and bone marrow fibrosis.
Can children use Darbitop 25mcg Injection?
Yes, Darbitop 25mcg Injection is used to treat anemia in children over the age of 1 year due to chronic kidney disease. The effectiveness and side effects of this medication are similar in children as they are in adults.
Can Darbitop 25mcg Injection affect blood pressure?
Yes, Darbitop 25mcg Injection can impact blood pressure. During initial therapy, it's essential to monitor your blood pressure and take measures to control high blood pressure if necessary.
Who should not use Darbitop 25mcg Injection?
Individuals with cancer who have not been prescribed this medication by their doctor should not take it. Additionally, those with uncontrolled hypertension, a history of pure red cell aplasia (PRCA) after treatment with Darbitop 25mcg Injection or other erythropoietin medications, and patients with a history of serious allergic reactions to this medicine should avoid using Darbitop 25mcg Injection.
